From root@aspensys.com Wed Jun 21 13:51:02 1995 Date: Wed, 21 Jun 1995 17:05:06 +0500 CENTERS FOR DISEASE CONTROL AND PREVENTION HIV/AIDS PREVENTION CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN ................................................................. May 30, 1995 #142 This is the answer from the Centers for Disease Control and Prevention (CDC) to a question submitted by the CDC National AIDS Hotline concerning the risk of contracting HIV from organ transplants. 1. Recently several callers have inquired about the risk of contracting HIV from transplanted organs. At present the only information we have is a brief paragraph on organ, bone, and tissue transplants from 1993. It reads as follows: "Each of these has been implicated in at least one case of HIV transmission. Since the testing of organ donors has been established, we do not expect to see many more cases such as these. People concerned about their risk should be encouraged to talk with their doctors." We are wondering if there is any new or additional information that we should include in a discussion of this issue. The exact risk of HIV-1 transmission from a seronegative organ or tissue donor is unknown, but probably very small. In most of the reports of transmission of HIV from tissue or organs, transplantation was performed before 1985, when screening of blood, organ, and tissue donors for HIV-1 antibody became routine. Three cases occurred after 1985. More than 60,000 organs and 1 million tissue allografts have been transplanted in the United States since routine donor screening for antibody to HIV-1 was instituted in 1985. (Reference: RJ Simonds, Holmberg SD, Hurwitz RL, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992;326:726-32.) Disclaimer: CDC Hotline Training Bulletins The information in the "CDC Hotline Training Bulletins" is provided by CDC and NIH for use by the CDC National AIDS Hotline in responding to general questions from the public about HIV and AIDS. The bulletins are not intended to be comprehensive discussions of the subject areas. Treatment and drug therapy options change as new research and clinical experiences broaden scientific knowledge. Therefore, persons seeking information on drug therapy should refer to the product information sheet included in all drug packages for the most current and accurate information about a particular drug, especially if the drug is new or infrequently used. HIV-infected individuals should consult their personal physician for specific concerns about their health. For persons desiring more information on a specific topic, public, medical, and university libraries can provide excellent references. The AIDS Clinical Trials Information Service (800-874-2572) can provide information about ongoing HIV/AIDS clinical trials; the HIV/AIDS Treatment Information Service (800-448-0440) can assist with information about the latest treatments for persons with HIV infection or AIDS.